Search
for

    Sort by

    Research 541–570 of 1000+

    1. 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes NeuroSci · 2026
    2. The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations Zenodo (CERN European Organization for Nuclear Research) · 2026
    3. The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations Zenodo (CERN European Organization for Nuclear Research) · 2026
    4. Injectable Therapy for Androgenetic Alopecia: A Systematic Review Dermatologic Surgery · 2026
    5. Tratamiento con Exosomas en Alopecia Areata Difusa Refractaria en Paciente Pediátrico: Reporte de Caso Ciencia Latina Revista Científica Multidisciplinar · 2026
    6. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    7. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    8. The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations GSC Biological and Pharmaceutical Sciences · 2026
    9. Tratamiento con Exosomas en Alopecia Areata Difusa Refractaria en Paciente Pediátrico: Reporte de Caso Ciencia Latina Revista Científica Multidisciplinar · 2026
    10. Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System Journal of Dermatological Treatment · 2026
    11. What is the best treatment for androgenic alopecia? Zenodo (CERN European Organization for Nuclear Research) · 2026
    12. What is the best treatment for androgenic alopecia? Zenodo (CERN European Organization for Nuclear Research) · 2026
    13. No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study Journal of the American Academy of Dermatology · 2026
    14. Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study Yonsei Medical Journal · 2026
    15. Combined Regenerative Technique: Tattoo Machine–Assisted Drug Delivery for Androgenetic Alopecia International Society of Hair Restoration Surgery · 2026
    16. Microneedling for Androgenetic Alopecia: A Synergistic Strategy Enhancing Drug Delivery and Follicular Regeneration Dermatologic Therapy · 2026
    17. Az androgén alopecia korszerű kezelése = Modern treatment of androgenetic alopecia Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) · 2026
    18. Suicidal ideation in patients undergoing treatment with 5α-reductase inhibitors Instituto Politécnico do Porto · 2025
    19. Farmácia dos Clérigos - Porto e nos Serviços Farmacêuticos da University College Hospital - Londres, Reino Unido, ao abrigo do programa Erasmus+ Open Repository of the University of Porto (University of Porto) · 2025
    20. COMPLICAÇÕES DOS TRATAMENTOS DA ALOPÉCIA ANDROGÉNICA: REVISÃO SISTEMÁTICA E META-ANÁLISE Revista fisio&terapia. · 2025
    21. Consensus Document on the Clinical Management of Frontal Fibrosing Alopecia: Recommendations From Spanish Working Group on Trichology and Onychology of the AEDV Actas Dermo-Sifiliográficas · 2025
    22. Revisión y avances en tricología Medicine - Programa de Formación Médica Continuada Acreditado · 2025
    23. Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar 2025
    24. NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL International Journal of Apllied Mathematics · 2025
    25. Farmácia Aliança - Maia Open Repository of the University of Porto (University of Porto) · 2025
    26. Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia. PubMed · 2025
    27. 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action Cosmetics · 2025
    28. Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system The Journal of Sexual Medicine · 2025
    29. Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies ACS Omega · 2025
    30. A eficácia da mesoterapia em tratamentos de alopecia: revisão integrativa da literatura SciELO (SciELO Preprints) · 2025